Does CANAKINUMAB Cause Mobility decreased? 50 Reports in FDA Database

Q: Does CANAKINUMAB cause Mobility decreased?

50 reports of Mobility decreased have been filed with the FDA for CANAKINUMAB, representing 0.5% of all CANAKINUMAB adverse event reports.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Mobility decreased have been filed in association with CANAKINUMAB (Ilaris). This represents 0.5% of all adverse event reports for CANAKINUMAB.

Reports of Mobility decreased with CANAKINUMAB

0.5%

of all CANAKINUMAB reports

Deaths

Hospitalizations

How Dangerous Is Mobility decreased From CANAKINUMAB?

Of the 50 reports, 29 (58.0%) required hospitalization.

Is Mobility decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CANAKINUMAB. However, 50 reports have been filed with the FAERS database.

What Other Side Effects Does CANAKINUMAB Cause?

Pyrexia (1,327) Inappropriate schedule of drug administration (1,238) Drug ineffective (1,078) Inappropriate schedule of product administration (944) Pain (858) Condition aggravated (771) Malaise (684) Off label use (557) Arthralgia (555) Rash (505)

What Other Drugs Cause Mobility decreased?

ADALIMUMAB (8,829) ETANERCEPT (8,321) METHOTREXATE (5,936) ABATACEPT (4,519) TOCILIZUMAB (4,403) LEFLUNOMIDE (4,354) HYDROXYCHLOROQUINE (4,105) RITUXIMAB (4,067) INFLIXIMAB (3,784) TOFACITINIB (3,734)

Which CANAKINUMAB Alternatives Have Lower Mobility decreased Risk?

CANAKINUMAB vs CANDESARTAN CANAKINUMAB vs CANDESARTAN CILEXETIL CANAKINUMAB vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE CANAKINUMAB vs CANGRELOR CANAKINUMAB vs CANIS LUPUS FAMILIARIS SKIN

CANAKINUMAB Full Profile All Mobility decreased Reports All Drugs Causing Mobility decreased CANAKINUMAB Demographics